These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 27218672

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term outcomes following percutaneous hepatic vein recanalization for Budd-Chiari syndrome.
    Tripathi D, Sunderraj L, Vemala V, Mehrzad H, Zia Z, Mangat K, West R, Chen F, Elias E, Olliff SP.
    Liver Int; 2017 Jan; 37(1):111-120. PubMed ID: 27254473
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interventional Treatment Strategy for Primary Budd-Chiari Syndrome with Both Inferior Vena Cava and Hepatic Vein Involvement: Patients from Two Centers in China.
    Cheng DL, Xu H, Li CL, Lv WF, Li CT, Mukhiya G, Fang WW.
    Cardiovasc Intervent Radiol; 2019 Sep; 42(9):1311-1321. PubMed ID: 31218407
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Percutaneous transjugular direct porto-caval shunt in patients with Budd-Chiari syndrome.
    Quateen A, Pech M, Berg T, Bergk A, Podrabsky P, Felix R, Ricke J.
    Cardiovasc Intervent Radiol; 2006 Sep; 29(4):565-70. PubMed ID: 16729230
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Good Clinical Outcomes in Budd-Chiari Syndrome with Hepatic Vein Occlusion.
    Fan X, Liu K, Che Y, Wang S, Wu X, Cao J, Li J.
    Dig Dis Sci; 2016 Oct; 61(10):3054-3060. PubMed ID: 27221497
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome.
    Tripathi D, Macnicholas R, Kothari C, Sunderraj L, Al-Hilou H, Rangarajan B, Chen F, Mangat K, Elias E, Olliff S.
    Aliment Pharmacol Ther; 2014 Apr; 39(8):864-72. PubMed ID: 24611957
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Risk factors for and causes and treatment of recurrence of inferior vena cava type of Budd-Chiari syndrome after stenting in China: A retrospective analysis of a large cohort.
    Li WD, Yu HY, Qian AM, Rong JJ, Zhang YQ, Li XQ.
    Eur Radiol; 2017 Mar; 27(3):1227-1237. PubMed ID: 27387875
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transjugular intrahepatic portosystemic shunt creation in Budd-Chiari syndrome: percutaneous ultrasound-guided direct simultaneous puncture of the portal vein and vena cava.
    Boyvat F, Aytekin C, Harman A, Ozin Y.
    Cardiovasc Intervent Radiol; 2006 Mar; 29(5):857-61. PubMed ID: 16810460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.